Home › Funds › Alessandra Capital Management, LLC › BEAM
Alessandra Capital Management, LLC position in BEAM
Beam Therapeutics Inc · Health Care
Alessandra Capital Management, LLC reported holding 56,945 shares of BEAM (Beam Therapeutics Inc) in its Q2 2026 13F filing — a position valued at US$2.0M, representing 1.38% of its reported portfolio and ranking #18 among its reported holdings. Alessandra Capital Management, LLC has disclosed BEAM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Alessandra Capital Management, LLC's BEAM position evolved
Alessandra Capital Management, LLC first disclosed a stake in BEAM in Q4 2025 at 51,075 shares (US$1.4M). The position peaked in Q2 2026 at 56,945 shares, worth US$2.0M. Across 3 filings, Alessandra Capital Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 56,945 shares valued at US$2.0M — a reduction of -5,661 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 51.08K | $1.42M | New |
| Q1 2026 | 62.61K | $1.49M | Add |
| Q2 2026 | 56.95K | $1.95M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BEAM and 13F data
BEAM (Beam Therapeutics Inc) is a Health Care company. 35 other funds we track also report a position in BEAM — the largest reported positions include Farallon Capital Management (US$351.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$351.3M), ARK Invest (US$351.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BEAM
- Farallon Capital Management 10.24M sh · $351.31M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 10.24M sh · $351.31M · Q2 2026
- ARK Invest 10.23M sh · $351.26M · Q2 2026
- ARCH Venture Management, LLC 4.54M sh · $155.77M · Q2 2026
- Amova Asset Management Americas, Inc. 3.46M sh · $118.54M · Q2 2026
- Kynam Capital Management, LP 2.84M sh · $97.50M · Q2 2026
- Contrarius Group Holdings Ltd 1.61M sh · $55.41M · Q2 2026
- Casdin Capital 1.35M sh · $46.33M · Q2 2026
- Redmile Group, LLC 1.16M sh · $39.96M · Q2 2026
- Deep Track Capital, LP 1.00M sh · $34.32M · Q2 2026
More on Alessandra Capital Management, LLC
FAQ
How long has Alessandra Capital Management, LLC held BEAM?
Alessandra Capital Management, LLC has disclosed BEAM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Alessandra Capital Management, LLC's current position in BEAM?
As of Q2 2026, Alessandra Capital Management, LLC holds 56.95K shares of BEAM (Beam Therapeutics Inc), valued at $1.95M, representing 1.38% of its reported portfolio and ranking #18.
Has Alessandra Capital Management, LLC been buying or selling BEAM?
In the latest 13F filing (Q2 2026), Alessandra Capital Management, LLC reduced its position in BEAM. The position peaked in Q2 2026 at 56.95K shares.
Which other funds hold BEAM?
Other major institutional holders of BEAM include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., ARK Invest, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.